SCOPUS 정보 검색 플랫폼

Gastroenterologie Clinique et Biologique

Volumn 26, Issue SPEC. 2, 2002, Pages

Treatment of hepatitis C in intravenous drug users;Traitement de l'hépatite C et usage de drogue

(1) Filoche, Bernard a

a Centre Hospitalier Saint Philibert GHICL (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; ANTIVIRUS AGENT; INTERFERON; PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADULT; ALCOHOL INTOXICATION; BLOOD TRANSFUSION; CHRONIC HEPATITIS; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; DRUG INDUCED DISEASE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; REINFECTION; VIRUS HEPATITIS;

ADULT; ANTIVIRAL AGENTS; BLOOD TRANSFUSION; FOLLOW-UP STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INTERFERONS; MENTAL DISORDERS; PROGNOSIS; RECURRENCE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 17144474566 PISSN: 03998320 EISSN: None Source Type: Journal
DOI: None Document Type: Conference Paper

Times cited : (3)

References (35)

1
- 7144262407
- Epidémiologie de l'infection virale C chez 1 304 sujets VHC positif. Variations en fonction du mode de contamination et de l'année du diagnostic
- (1998) Gastroenterol Clin Biol , vol.22 , pp. 375-380
- Guyader, D.¹ Lefeuvre, C.² Jacquelinet, S.³ Prat, M.⁴ Baudouard, Y.⁵ Turlin, B.⁶

2
- 0000418124
- Conclusions et recommandations du jury. Texte long. Hépatite C: Dépistage et traitement
- (1997) Gastroenterol Clin Biol , vol.20

3
- 0001445884
- National institutes of Health Consensus Development Conference Panel Statement: Management of hepatitis C
- (1997) Hepatology , vol.26 , Issue.SUPPL.

4
- 0032775044
- Conférence internationale de consensus sur l'hépatite C. Conclusions
- (1999) Gastroenterol Clin Biol , vol.23 , pp. 730-735

5
- 0035934568
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: Results of a randomised trial
- (2001) Lancet , vol.358 , pp. 958-965
- Manns, M.P.¹ McHutchison, J.G.² Gordon, S.C.³ Rustgi, V.K.⁴ Shiffman, M.⁵ Reindollar, R.⁶

6
- 0000970711
- Effets de l'interféron alpha 2a pégylé [Pegasys] associé á la ribavirine dans l'hépatite chronique virale C. Etude randomisée multicentrique
- (2001) Gastroenterol Clin Biol , vol.25
- Dhumeaux, D.¹ Hézode, C.² Fried, M.W.³ Shiffman, M.L.⁴ Reddy, R.K.⁵ Smith, C.⁶

7
- 0032748876
- Hepatitis C virus genotypes in France: Relationship with epidemiology, pathogenicity and response to interferon therapy
- (1999) J Viral Hepat , vol.6 , pp. 435-443
- Martinot-Peignoux, M.¹ Roudot-Thoraval, F.² Mendel, I.³ Coste, J.⁴ Izopet, J.⁵ Duverlie, G.⁶

8
- 0033932001
- Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome
- (2000) Semin Liver Dis , vol.20 , pp. 17-35
- Alter, H.J.¹ Seef, L.B.²

9
- 0033584440
- The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
- (1999) N Engl J Med , vol.341 , pp. 556-562
- Alter, M.J.¹ Kruszon-Moran, D.² Nainan, O.V.³ McQuillan, G.M.⁴ Gao, F.⁵ Moyer, L.A.⁶

10
- 0030933395
- Natural history of liver fibrosis progression in patients with chronic hepatitis C
- (1997) Lancet , vol.349 , pp. 825-832
- Poynard, T.¹ Bedossa, P.² Opolon, P.³

11
- 0031721879
- Impact of alcohol on the histological and clinical progression of hepatitis C infection
- (1998) Hepatology , vol.28 , pp. 805-809
- Wiley, T.E.¹ McCarthy, M.² Breidi, L.³ McCarthy, M.⁴ Layden, T.J.⁵

12
- 0032101819
- Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users
- (1998) J Hepatol , vol.28 , pp. 945-950
- Pol, S.¹ Lamorthe, B.² Trinh Thi, N.³ Thiers, V.⁴ Carnot, F.⁵ Zylberberg, H.⁶

13
- 0032837102
- Liver fibrosis progression in human immunodeficiency virus and hepatic virus coinfected patients
- (1999) Hepatology , vol.30 , pp. 1054-1058
- Benhamou, Y.¹ Bochet, M.² Di Martino, V.³ Charlotte, F.⁴ Azria, F.⁵ Coutelier, A.⁶

14
- 19244377701
- Characteristics of patients with dual infection by hepatitis B and C viruses
- (1998) J Hepatol , vol.28 , pp. 27-33
- Zarski, J.P.¹ Bohn, B.² Bastie, A.³ Pawlotsky, J.M.⁴ Baud, M.⁵ Bost-Bezeaux, F.⁶

15
- 0035811625
- Hepatitis C virus infection
- (2001) N Engl J Med , vol.345 , pp. 41-52
- Lauer, G.M.¹ Walker, B.D.²

16
- 0030800166
- Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patients
- (1997) Hepatology , vol.26 , pp. 485-490
- Roudot-Thoraval, F.¹ Bastie, A.² Pawlotsky, J.M.³ Dhumeaux, D.⁴

17
- 0035009810
- Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C
- (2001) J Hepatol , vol.34 , pp. 730-739
- Poynard, T.¹ Ratziu, V.² Charlotte, F.³ Goodman, Z.⁴ McHutchison, J.⁵ Albrecht, J.⁶

18
- 0033839753
- Assessment of long term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975
- (2000) Hepatology , vol.32 , pp. 582-587
- Rodger, A.J.¹ Roberts, S.² Lanigan, A.³ Bowden, S.⁴ Brown, T.⁵ Crofts, N.⁶

19
- 0034718227
- The natural history of hepatitis C virus infection. Host, viral and environmental factors
- (2000) JAMA , vol.284 , pp. 450-456
- Thomas, D.L.¹ Astemborski, J.² Rai, R.M.³ Anania, F.A.⁴ Schaeffer, M.⁵ Galai, N.⁶

20
- 0032481753
- Rapidité d'évolution vets la cirrhose après hépatite C: Influence de l'âge au moment de la contamination par le virus
- (1998) Presse Med , vol.27 , pp. 608-611
- Lucidarme, D.¹ Dumas, F.² Arpurt, J.P.³ Pariente, E.A.⁴ Naudin, G.⁵ Forzy, G.⁶

21
- 0029901049
- Mortality trends in a cohort of opiate addicts, Catalonia, Spain
- (1996) Intern J Epidemiol , vol.25 , pp. 545-553
- Orti, R.M.¹ Domingo-Salvany, A.² Munoz, A.³ McFarlane, D.⁴ Suelves, J.M.⁵ Anto, J.M.⁶

22
- 0030062624
- Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus [HIV]-positive and HIV-negative drug users
- (1996) Am J Epidemiol , vol.143 , pp. 380-391
- Van Haastrecht, H.J.¹ Van Ameijden, E.J.² Vanden Hoek, J.A.³ Mientjes, G.H.⁴ Bas, J.S.⁵ Coutinho, R.A.⁶

23
- 0003107596
- Que dire, que faire en cas de toxicomanie accompagnée d'hépatite virale C?
- (1999) Hepato-Gastro , vol.6 , pp. 32-35
- Edel, Y.¹

24
- 0030056560
- Effets secondaires de l'interféron alpha
- (1996) Gastroenterol Clin Biol , vol.20 , pp. 462-489
- Vial, T.¹ Bailly, F.² Descotes, J.³ Trépo, C.⁴

25
- 0030039651
- A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon
- (1996) J Hepatol , vol.24 , pp. 38-47
- Fattovich, G.¹ Giustina, G.² Favarato, S.³ Ruol, A.⁴

26
- 0026767691
- Lack of protective immunity against reinfection with hepatitis C virus
- (1992) Science , vol.258 , pp. 135-140
- Farci, P.¹ Alter, H.J.² Govindarajan, S.³ Wong, D.C.⁴ Engle, R.⁵ Lesniewski, R.R.⁶

27
- 0028158455
- Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children
- (1994) Lancet , vol.343 , pp. 388-390
- Lai, M.E.¹ Mazzoleni, A.P.² Argiolu, F.³ De Virgilis, S.⁴ Balestrieri, A.⁵ Purcell, R.H.⁶

28
- 0033890784
- Two successive hepatitis C virus infections in an intravenous drug user
- (2000) J Clin Microbiol , vol.38 , pp. 3125-3127
- Proust, B.¹ Dubois, F.² Bacq, Y.³ Le Pogam, S.⁴ Rogez, S.⁵ Levillain, R.⁶

29
- 0001317653
- Le diagnostic de l'infection par le virus de l'hépatite C (VHC) sur prélèvement salivaire pourrait permettre de dépister tous les sujets virémiques
- (1999) Gastroenterol Clin Biol , vol.23
- Lucidarme, D.¹ Decoster, A.² Hussenet, F.³ Harbonnier, J.⁴ Jacob, C.⁵ Foutrein, P.⁶

30
- 0034956562
- Treatment of hepatitis C infection in injection drug users
- (2001) Hepatology , vol.34 , pp. 188-193
- Backmund, M.¹ Meyer, K.² Von Zielonka, M.³ Eichenlaub, D.⁴

31
- 0035081510
- Managing chronic hepatitis C acquired through intravenous drug use
- (2001) QJM , vol.94 , pp. 153-158
- Jowett, S.L.¹ Agarwal, K.² Smith, B.C.³ Craig, W.⁴ Hewett, M.⁵ Bassendine, D.R.⁶

32
- 0032585237
- Randomised trial of interferon alfa 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alfa 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
- (1998) Lancet , vol.352 , pp. 1426-1432
- Poynard, T.¹ Marcellin, P.² Lee, S.S.³ Niederau, C.⁴ Minuk, G.S.⁵ Gaetano, I.⁶

33
- 0032547938
- Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
- (1998) N Engl J Med , vol.339 , pp. 1485-1492
- McHutchison, J.G.¹ Gordon, S.C.² Schiff, E.R.³ Shiffman, M.L.⁴ Lee, W.M.⁵ Rustgi, V.K.⁶

34
- 0032101819
- Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users
- (1998) J Hepatol , vol.28 , pp. 945-950
- Pol, S.¹ Lamorthe, B.² Trinh Thi, N.³ Thiers, V.⁴ Camot, F.⁵ Zylberberg, H.⁶

35
- 0035913261
- Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?
- (2001) N Engl J Med , vol.345 , pp. 211-214
- Edlin, B.R.¹ Seal, K.H.² Lorvick, J.³ Kral, A.H.⁴ Ciccarone, D.H.⁵ Moore, L.D.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.